Restarting Clopidogrel After Hemorrhagic Stroke

Initial Management After Hemorrhagic Stroke

The American Heart Association recommends that all antiplatelet agents, including clopidogrel, should be immediately discontinued in patients presenting with hemorrhagic stroke 3
The American College of Cardiology suggests that the anticoagulant effect should be reversed immediately with appropriate agents if the patient was on anticoagulants 2, 1
During the acute phase (first 1-2 weeks), antiplatelet therapy should be withheld to minimize the risk of hematoma expansion, as recommended by the American Heart Association 1, 2

The decision to restart antithrombotic therapy depends on balancing the risk of subsequent arterial or venous thromboembolism, according to the American Heart Association 1
The overall neurological status of the patient should be considered when deciding to restart antithrombotic therapy, as suggested by the American College of Cardiology 1, 4

For patients with very high thromboembolism risk, it may be reasonable to restart clopidogrel at 7-10 days after the original hemorrhage, as recommended by the American Heart Association 1
For most patients, waiting at least 1-2 weeks is recommended before considering restarting antiplatelet therapy, according to the American College of Cardiology 2
A brain imaging study (CT or MRI) should be performed before restarting therapy to ensure the hemorrhage has stabilized, as suggested by the American College of Radiology 5

Patients with lobar intracerebral hemorrhage (ICH) or evidence of cerebral amyloid angiopathy are at higher risk of recurrent hemorrhage, according to the American Heart Association 2, 1
Elderly patients with lobar ICH are at higher risk of recurrent hemorrhage, as suggested by the American Geriatrics Society 1
Patients with multiple microbleeds on MRI are at higher risk of recurrent hemorrhage, according to the American Heart Association 4
Patients with very poor overall neurological function are at higher risk of recurrent hemorrhage, as suggested by the American College of Cardiology 1

Patients with mechanical heart valves are at higher risk of thromboembolism, according to the American College of Cardiology 2
Patients with high CHADS2 score (≥4 points) for atrial fibrillation are at higher risk of thromboembolism, as suggested by the American Heart Association 6

Discontinue clopidogrel immediately upon diagnosis of hemorrhagic stroke, as recommended by the American Heart Association 3, 1
Wait at least 1-2 weeks after the hemorrhage before considering restarting therapy, according to the American College of Cardiology 2, 1
Obtain brain imaging before restarting to confirm hemorrhage stabilization, as suggested by the American College of Radiology 5
For patients with very high thromboembolism risk, consider restarting clopidogrel at 7-10 days after the original hemorrhage, as recommended by the American Heart Association 1
For patients with lobar hemorrhage or suspected cerebral amyloid angiopathy, consider longer delay or alternative strategies, according to the American College of Cardiology 2, 1

For patients with hemorrhagic transformation of ischemic stroke (rather than primary ICH), antiplatelet therapy may be continued depending on the specific clinical scenario and underlying indication, as suggested by the American Heart Association 2, 1
In patients with a comparatively lower risk of cerebral infarction and higher risk of amyloid angiopathy, an antiplatelet agent may be considered for prevention of ischemic stroke, according to the American College of Cardiology 1
Consider consultation with specialists (stroke neurologist, cardiologist, hematologist) for complex cases, as recommended by the American Heart Association 3